SCHEMBL19243246

SCHEMBL19243246

B/C(C)=C(/C=O)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
TDP1 Q9NUW8 2/20 0.48
MAPK1 P28482 1/20 0.48
TSHR P16473 4/20 0.43
CES2 O00748 3/20 0.43
CES1 P23141 3/20 0.43
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA9 Q16790 2/20 0.39
AKR1C3 P42330 1/20 0.39
DAO P14920 1/20 0.39
NAPRT Q6XQN6 1/20 0.39
AKR1C1 Q04828 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
MAPT P10636 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10456489 0.84 ALDH1A1 (0.50) ALDH1A1TDP1MAPK1TSHRCES2
SCHEMBL9615018 0.83 ALDH1A1 (0.59) ALDH1A1TDP1MAPK1TSHRCES2
SCHEMBL9615016 0.83 ALDH1A1 (0.59) ALDH1A1TDP1MAPK1TSHRCES2
SCHEMBL27469663 0.82 ALDH1A1 (0.48) ALDH1A1TDP1MAPK1TSHRCES2
SCHEMBL19209092 0.80 ALDH1A1 (0.46) ALDH1A1TDP1MAPK1TSHRCES2
SCHEMBL1798594 0.80 ALDH1A1 (0.46) ALDH1A1TDP1MAPK1TSHRCES2
SCHEMBL7525187 0.80 ALDH1A1 (0.52) ALDH1A1TDP1MAPK1TSHRCES2
SCHEMBL19209090 0.80 ALDH1A1 (0.46) ALDH1A1TDP1MAPK1TSHRCES2
SCHEMBL19243244 0.80 ALDH1A1 (0.46) ALDH1A1TDP1MAPK1TSHRCES2
SCHEMBL27736881 0.80 ALDH1A1 (0.46) ALDH1A1TDP1MAPK1TSHRCES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017134555-A1 DERIVATIVES OF PYRROLOIMIDAZOLE OR ANALOGUES THEREOF WHICH ARE USEFUL FOR THE TREATMENT OF INTER ALIA CANCER EMCURE PHARMACEUTICALS LIMITED (IN) 2017-08-10 WO disclosed